A multi-award winning company has received another top accolade for its ground-breaking technology which will turn any smart watch into a glucose monitor. 

Afon Technology was presented with Junkosha’s Technology Innovator of the Year Award and a $25,000 prize today in recognition of its Glucowear™ device, which represents a significant step forward in the development of non-invasive glucose monitoring.  

The Award is designed to spotlight the achievements of pioneers in advanced technologies from across the globe. 

In recent years there has been widespread discussion surrounding the integration of optical sensors into smartwatches for glucose monitoring purposes. However, despite significant advancements in optical sensor technology, there remains a persistent gap between concept and real-world implementation.  

Afon’s Glucowear adopts an entirely different approach. Unlike optical sensors, Glucowear utilises radio frequency (RF) sensors to provide continuous glucose monitoring. 

These sensors, strategically placed beneath the base of the wearer's wrist, utilise radio waves to detect and transmit glucose data.  

One of the key advantages of Glucowear lies in its ability to provide real-time glucose readings, eliminating the time lag associated with existing continuous glucose monitors. The device can also be used on all skin colours. This instantaneous access to glucose data enables individuals to manage their diabetes more effectively and make informed lifestyle choices. 

“Junkosha’s Technology Innovator of the Year Award is committed to recognising talent within key markets that the company serves worldwide. At the core of the Junkosha brand message is our commitment to enabling technology innovators. Over the past year the judges had a very tough decision to make, but the quality of Afon’s work was truly impressive”, explained Joe Rowan, Chairperson for the Award. “Sabih Chaudhry and the team not only met all the criteria that Junkosha was looking for; they exceeded our expectations. Their entry showcased not only bold challenges to be overcome but also ground-breaking innovation and societal benefit – attributes at the core of the Junkosha brand.”

With entries representing countries as far away as Morocco, Belgium, Turkey and the United States, the second instalment of the Awards have included a very high calibre of entries from across the fields of Interventional Medical procedures and Microwave/Millimeter Wave technologies.

Mamoru Sogo, President and CEO of Junkosha Inc., added: “Our mission ‘Enabling Technology Innovators’ is a commitment to contribute to our society for a better future. 

“This Award ceremony serves as a testament to this commitment to support those who, like Junkosha, are taking on the challenge of long-lasting technological innovation and contributing to society. We congratulate Sabih and Afon Technology on this remarkable achievement and look forward to witnessing their continued success.”

Sabih Chaudhry, CEO for Afon Technology, said: “Winning this Award is testament to the dedication and outstanding skillset of our team. 

“At Afon, our driving force is our passion for pushing technological boundaries to enhance patient outcomes, so being recognised for changing the landscape of continuous glucose monitoring is an honour. 

“We take immense pride in pioneering the world’s first non-invasive blood glucose monitoring device. We firmly believe it holds the potential to revolutionise the lives of individuals living with diabetes, offering a needle-free alternative for monitoring blood sugar levels.”

The company is celebrating half a decade in business as it edges closer to transforming the realm of continuous glucose monitoring.    

Afon Technology opened its doors in 2019 and started creating the world's first non-invasive wearable blood glucose sensor – a move which is set to make life easier for people with diabetes by removing the need for needles when monitoring blood sugar levels.  

This milestone marks a significant achievement for the Monmouthshire-based tech firm as it leads the race in revolutionising blood glucose monitoring.